“Rise of Connected Drug Delivery Devices in North America”
- Connected drug delivery devices, such as smart inhalers and autoinjectors, are gaining popularity for their ability to provide real-time data to both patients and healthcare providers, improving treatment outcomes and adherence
- For instance, the Propeller Health smart inhaler system has been adopted by healthcare systems in the U.S. to monitor asthma and COPD patients remotely
- The integration of digital health technologies into drug delivery devices allows for features such as dose tracking, reminders, and real-time data sharing, enabling personalized treatment plans and remote monitoring
- For instance, is the BD Libertas wearable injector, which offers connectivity features for tracking and reporting injection data in real-time
- Companies such as Jabil Healthcare and Aptar Pharma have introduced connected platforms and digital respiratory health solutions, respectively, showcasing the industry's commitment to innovation in this space
- The growing prevalence of chronic diseases and the shift towards patient-centric healthcare are driving the demand for connected drug delivery devices that empower patients in managing their treatments effectively
- The North American market's emphasis on technological adoption and supportive regulatory frameworks further accelerates the growth and acceptance of connected drug delivery solutions
